The Food and Drug Administration issued an untitled letter to Ascend Therapeutics for claims made in its EstroGel promotions. The offending promotional material was a sell sheet distributed to ...
ANI Pharmaceuticals (ANIP) announced that following final approval from the U.S. FDA for its Abbreviated New Drug Application, the company launched Estradiol Gel, 0.06%. ANI’s Estradiol Gel, 0.06% is ...
March 11, 2004 — The U.S Food and Drug Administration (FDA) recently approved four new advances: a drug that is the first in its class for the treatment of chronic kidney disease, a new scanner for ...
Oct. 19, 2004 -- Transdermal estradiol gel is effective in reducing the frequency and severity of moderate to severe hot flushes in postmenopausal women, with a lower frequency of skin reactions than ...